Takeda Accused Of Hiding Diabetes Drug's Cancer Link

Law360, New York (August 2, 2011, 10:50 PM EDT) -- Takeda Pharmaceutical Co. Ltd. was hit Tuesday in California with what is expected to be the first of thousands of suits accusing the company of failing to warn consumers that taking its diabetes drug Actos could lead to an aggressive form of bladder cancer.

Japan-based Takeda allegedly concealed epidemiological studies showing a connection between prolonged use of Actos, a drug used to improve blood sugar control in adults with Type 2 diabetes, and increased risk of bladder cancer.

Plaintiff Jules Berck claims he would not have...
To view the full article, register now.